Magnetically controlling release of drug involves applying composite coating with magnetic nanoparticles of zinc oxide-manganese oxide-iron oxide to implant, placing implant in body, and impacting device and release of active substance
	KRITSKAYA E A; PYATAKOV A P; VYLEGZHANIN A G
	2018-07-12
Rights Holder	SHEL LLC (SHEL-Non-standard)
Application Date	2018-07-12
Patent Number	RU2018125759-A
Abstract	NOVELTY - Magnetically controlling the release of drug, comprises applying a composite coating with magnetic nanoparticles of zinc oxide-manganese oxide-iron oxide (ZnO.1MnO.9Fe2O4) to an implant in a film of the thermosensitive polymer poly(N-isopropylacrylamide), placing the implant in the patient's body, and impacting the implanted device and the subsequent release of the active substance by controlling the reversible phase transition between the hydrophobic and hydrophilic states using an alternating magnetic field (at amplitude of 100 Oe, 100 kHz). USE - The method is useful for magnetically controlling the release of drug.
IPC Classification Number	A61K-009/00
Country	俄罗斯
Professional field	医药卫生
Language	英语
Achievement type	专利
Document Type	科技成果
Identifier	http://119.78.100.226:8889/handle/3KE4DYBR/23344
Collection	中国科学院新疆生态与地理研究所
Affiliation	SHEL LLC (SHEL-Non-standard)
Recommended Citation GB/T 7714	KRITSKAYA E A,PYATAKOV A P,VYLEGZHANIN A G. Magnetically controlling release of drug involves applying composite coating with magnetic nanoparticles of zinc oxide-manganese oxide-iron oxide to implant, placing implant in body, and impacting device and release of active substance. RU2018125759-A[P]. 2018.

Files in This Item:
There are no files associated with this item.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.